# Assystem acquires controlling stake in The Biotech Quality Group

Assystem acquired a 72.7% interest in The Biotech Quality Group, a Belgian consulting firm specializing in regulatory compliance for the pharmaceutical and biotech industries.

- Type: Acquisition
- Announced: 2017-12-05
- Where: Belgium, Belgium
- Status: announced
- Products: consulting services for regulatory compliance in pharma and biotech
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Assystem](https://endata.com/companies/2600.md) (acquirer)
- [The Biotech Quality Group](https://endata.com/companies/17983.md) (target)

## Sources

- [globenewswire.com](https://www.globenewswire.com/news-release/2017/12/05/1229326/0/en/ASSYSTEM-Reinforces-its-positions-in-the-Life-Sciences-sector-by-acquiring-a-controlling-interest-in-The-Biotech-Quality-Group.html), 2017-12-05: "The combined skills and expertise of BQG and Assystem will enable us to propose to the market a unique offering encompassing quality, regulatory compliance and performance at all stages of a drug's life cycle."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.